Carissa Thompson
Adult Health · Des Moines, IANPI 1548502453
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $514 of the $620 with a category attached, or 82.9%. 7 manufacturers reported payments, led by Beigene USA, Inc. at 20.2% of the total. Reporting peaked in 2023 at $210 and has fallen 51.1% since, to $103 in 2024.
Across 7 payments — averaging $88.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beigene USA, Inc.$125
- Jazz Pharmaceuticals Inc.$110
- Lilly USA, LLC$106
- Amgen$103
- G1 Therapeutics, Inc.$85
- Seagen Inc.$63
- plus $29 from 1 others
What the payments were for
- Food & beverage$51483%
- Education$10617%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beigene USA, Inc. | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 1 | $110 |
| Lilly USA, LLC | 1 | $106 |
| Amgen | 1 | $103 |
| G1 Therapeutics, Inc. | 1 | $85 |
| Seagen Inc. | 1 | $63 |
| GSK | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$620 in reported general payments places this provider in the 75th percentile of 77 adult health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JakafiRuxolitinib Phosphate | 11 | $162,740 |
| Oxycodone Hcl | 44 | $674 |
| Potassium Chloride | 29 | $464 |
| Morphine Sulfate ErMorphine Sulfate | 21 | $424 |
| Dexamethasone | 28 | $373 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $289 |
| Gabapentin | 26 | $280 |
| Anastrozole | 18 | $277 |
| Mirtazapine | 21 | $211 |
| Prednisone | 42 | $194 |
| Acyclovir | 27 | $192 |
| Prochlorperazine Maleate | 15 | $177 |
| Ondansetron Hcl | 26 | $115 |
| Levothyroxine Sodium | 23 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $104 |
Paid to pharmacies, not to this prescriber.
Other adult health in Des Moines
- Sandra HallDes Moines$671
- Catherine SmithDes Moines$614
- Sue Forkah-MusoroDes Moines$499
- Jessica EllensohnDes Moines$444
- Jill DuffyDes Moines$384
- Jennifer GreimannDes Moines$368
- Kristi BogsethDes Moines$309
- Melissa BattDes Moines$197
- Katharine TurpinDes Moines$180
- Julie YountDes Moines$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.